ALNY
Price
$359.27
Change
+$0.01 (+0.00%)
Updated
Jan 16 closing price
Capitalization
47.46B
25 days until earnings call
Intraday BUY SELL Signals
ALXO
Price
$1.17
Change
-$0.04 (-3.31%)
Updated
Jan 16 closing price
Capitalization
63.44M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALNY vs ALXO

Header iconALNY vs ALXO Comparison
Open Charts ALNY vs ALXOBanner chart's image
Alnylam Pharmaceuticals
Price$359.27
Change+$0.01 (+0.00%)
Volume$1.53M
Capitalization47.46B
ALX Oncology Holdings
Price$1.17
Change-$0.04 (-3.31%)
Volume$204.48K
Capitalization63.44M
ALNY vs ALXO Comparison Chart in %
View a ticker or compare two or three
VS
ALNY vs. ALXO commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a Hold and ALXO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (ALNY: $359.27 vs. ALXO: $1.17)
Brand notoriety: ALNY and ALXO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 107% vs. ALXO: 88%
Market capitalization -- ALNY: $47.46B vs. ALXO: $63.44M
ALNY [@Biotechnology] is valued at $47.46B. ALXO’s [@Biotechnology] market capitalization is $63.44M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 2 FA rating(s) are green whileALXO’s FA Score has 0 green FA rating(s).

  • ALNY’s FA Score: 2 green, 3 red.
  • ALXO’s FA Score: 0 green, 5 red.
According to our system of comparison, ALNY is a better buy in the long-term than ALXO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while ALXO’s TA Score has 5 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • ALXO’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ALXO is a better buy in the short-term than ALNY.

Price Growth

ALNY (@Biotechnology) experienced а -9.80% price change this week, while ALXO (@Biotechnology) price change was -13.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

ALNY is expected to report earnings on Feb 12, 2026.

ALXO is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($47.5B) has a higher market cap than ALXO($63.4M). ALXO YTD gains are higher at: 3.540 vs. ALNY (-9.652). ALNY has higher annual earnings (EBITDA): 187M vs. ALXO (-105.6M). ALNY has more cash in the bank: 2.73B vs. ALXO (60.6M). ALXO has less debt than ALNY: ALXO (10.1M) vs ALNY (1.31B). ALNY has higher revenues than ALXO: ALNY (3.21B) vs ALXO (0).
ALNYALXOALNY / ALXO
Capitalization47.5B63.4M74,921%
EBITDA187M-105.6M-177%
Gain YTD-9.6523.540-273%
P/E Ratio1197.57N/A-
Revenue3.21B0-
Total Cash2.73B60.6M4,497%
Total Debt1.31B10.1M12,950%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
29
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYALXO
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
65%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bearish Trend 3 days ago
68%
Bullish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
84%
Aroon
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signal:
Gain/Loss:
ALXO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FEUZ63.300.16
+0.26%
First Trust Eurozone AlphaDEX® ETF
ARLU30.720.02
+0.06%
AllianzIM U.S. Equity Buffer15 UncAprETF
APXM31.10N/A
N/A
FT Vest U.S. Equity Max Buffr ETF - Apr
JAVA74.66-0.17
-0.23%
JPMorgan Active Value ETF
SEIQ38.88-0.12
-0.31%
SEI Enhanced US Large Cap Qual Fac ETF

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with ARGX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+0.00%
ARGX - ALNY
52%
Loosely correlated
-1.63%
SGMO - ALNY
42%
Loosely correlated
-6.65%
IONS - ALNY
37%
Loosely correlated
-1.14%
ALLO - ALNY
37%
Loosely correlated
+1.24%
UTHR - ALNY
35%
Loosely correlated
-1.50%
More

ALXO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALXO has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALXO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALXO
1D Price
Change %
ALXO100%
-3.31%
MDGL - ALXO
56%
Loosely correlated
+1.17%
AXON - ALXO
45%
Loosely correlated
-0.18%
AMRN - ALXO
43%
Loosely correlated
-0.81%
ALNY - ALXO
39%
Loosely correlated
+0.00%
VERA - ALXO
36%
Loosely correlated
+0.50%
More